Are dividend payouts linked to equity ownership pattern – a case of the drugs and pharmaceutical industry

918 Words2 Pages

FINDINGS

Pharma Company D/E DPS
2005 2013 ACGR 2005 2013 ACGR

Dr Reddy Labs 5.4978 18.7173 16.5485 5 15 14.720269

Lupin Labs 11.005 6.20366 -6.9144 6.5 4 -5.888363

Glaxosmith Kline 0.043976 0.04888 1.32986 24 50 9.6086542

Sun Pharma 19.26678 0.41647 -38.078 3.75 5 3.661465

Cadila Healthcare 11.83121 16.0693 3.90133 6 7.5 2.8285594

Over the period of 2005-2013 , Dr.Reddy Labs has shown the highest growth of the dividend payouts of 14.72% and an corresponding D/E ratio increase of 18.71%. This points to the fact that Dr.Reddy Labs in the last 8 years , has had a aggressive growth strategy , financed by financial institutions in the form of long-term loans and advancements and is also has won the investor confidence by providing them a healthy growth in dividend returns.

All the companies (exception of Sun Pharma) have shown positive correlation between the D/E ratio and the DPS AGCR. Sun Pharma has shown positive growth in the DPS AGCR but decline in the D/E ratio as it has used up it’s cash to re-pay it’s outstanding debts in the year 2012. Sun Pharma has shown strong growth performance during this period and the correlation shows that dividend payouts can not on it’s own standing provide adequate outlook of the company’s performance.

Lupin Labs has shown negative growth in both it’s D/E and DPS during the period. The negative ACGR of DPS shows the shift in policy by the board of directors at Lupin to use the bludgeoning profits to further the growth plans of the company. Lupin , during this period has also undertaken FPO’s that has built their equity funds with a compounded growth rate of 10.57 % during this period. Lupin has ...

... middle of paper ...

... the study is limited to these 5 companies. No concrete judgment can be reached describing the exact relationship between the ownership pattern and the dividend payout , as many factors come into play while deciding on the dividend decisions. Such qualitative reasoning are hard to judge and include in determining the relationship. We have identified major trends and based our observations on the same.

Future scope of study can include more robust variables that could be used to build a better understanding of the factors that go into providing a dividend payout. A longer duration of study (we studied the company for 8 years) to reduce any short-term anomalies that may have arised in the performance of the companies. We would also like to provide for a comparison study on dividend patterns between pharma industry and the other industries prevalent in the country.

More about Are dividend payouts linked to equity ownership pattern – a case of the drugs and pharmaceutical industry

Open Document